Stock picks by Sameet Chavan: Buy Strides Pharma, sell Grasim

We finally witnessed a decisive price and volume breakout from the recent congestion zone in Strides Pharma

Nifty Outlook

We had a pathetic start for the week on Monday as Nifty surprisingly opened with a massive cut of more than 200 points as indicated by the SGX Nifty. This was mainly on the back of mounting concerns over the Covid-19 cases on the domestic front. Since it weighed down heavily on the financial space, the knock turned out to be a brutal one. In this process, the Nifty went on to tumble over 500 points to test the sub-14,300 territory. Things looked extremely scary at the close on the opening day; but fortunately there was no follow through